Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience

Author： Cristofanilli M. Holmes F.A. Esparza L. Valero V. Buzdar A.U. Neidhart J.A. Hortobagyi G.N.

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.54, Iss.3, 1999-04, pp. : 225-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial

By van Poznak C.

Breast Cancer Research and Treatment, Vol. 66, Iss. 3, 2001-04 ,pp. : 239-248

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer

By Mariani G.

Breast Cancer Research and Treatment, Vol. 70, Iss. 3, 2001-12 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of paclitaxel and vinorelbine in metastatic breast cancer

By Tortoriello A.

Breast Cancer Research and Treatment, Vol. 47, Iss. 1, 1998-01 ,pp. : 91-97

Springer Publishing Company

Access to resources Recommend Favorite

A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer

By Gluck S. Germond C. Lopez P. Cano P. Dorreen M. Koski T. Arnold A. Dulude H. Gallant G.

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1008-1014

Elsevier

Access to resources Recommend Favorite

Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center?

By Shen Yu Dong Wenli Esteva Francisco Kau Shu-Wan Theriault Richard Bevers Therese

Breast Cancer Research and Treatment, Vol. 102, Iss. 3, 2007-05 ,pp. : 347-356

Springer Publishing Company

Access to resources Recommend Favorite